2/27
10:53 am
cor
Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics [Yahoo! Finance]
Low
Report
Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics [Yahoo! Finance]
2/23
06:03 am
cor
Healthcare Logistics Industry Report 2026-2035: A $213.74 Billion Market by 2030 with AmerisourceBergen, CEVA Logistics, Cold Chain Technologies, Deutsche Post DHL Group, and UPS Healthcare Leading [Yahoo! Finance]
Low
Report
Healthcare Logistics Industry Report 2026-2035: A $213.74 Billion Market by 2030 with AmerisourceBergen, CEVA Logistics, Cold Chain Technologies, Deutsche Post DHL Group, and UPS Healthcare Leading [Yahoo! Finance]
2/20
05:22 am
cor
Bio-Pharmaceutical Logistics Market Report 2026-2035: A $259.32 Billion Market by 2030 with Kuehne + Nagel, FedEx, AmerisourceBergen, UPS, Kerry Logistics, and DB Schenker Leading [Yahoo! Finance]
Low
Report
Bio-Pharmaceutical Logistics Market Report 2026-2035: A $259.32 Billion Market by 2030 with Kuehne + Nagel, FedEx, AmerisourceBergen, UPS, Kerry Logistics, and DB Schenker Leading [Yahoo! Finance]
2/18
07:31 am
cor
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal [Yahoo! Finance Canada]
Low
Report
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal [Yahoo! Finance Canada]
2/18
07:21 am
cor
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal [Yahoo! Finance]
Low
Report
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal [Yahoo! Finance]
2/18
07:00 am
cor
Covetrus and MWI Animal Health to Merge
Low
Report
Covetrus and MWI Animal Health to Merge
2/13
04:15 pm
cor
Cencora Closes $3.0 Billion Senior Notes Offering
Low
Report
Cencora Closes $3.0 Billion Senior Notes Offering
2/13
07:17 am
cor
Cencora (NYSE:COR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Cencora (NYSE:COR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/10
05:15 pm
cor
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
Low
Report
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
2/10
03:28 pm
cor
Cencora (NYSE:COR) had its price target raised by analysts at JPMorgan Chase & Co. from $417.00 to $419.00. They now have an "overweight" rating on the stock.
Low
Report
Cencora (NYSE:COR) had its price target raised by analysts at JPMorgan Chase & Co. from $417.00 to $419.00. They now have an "overweight" rating on the stock.
2/10
07:13 am
cor
Cencora (NYSE:COR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Cencora (NYSE:COR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
2/9
10:51 am
cor
Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors [Yahoo! Finance]
Low
Report
Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors [Yahoo! Finance]
2/6
06:44 pm
cor
Cencora (NYSE:COR) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b)" rating.
Low
Report
Cencora (NYSE:COR) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b)" rating.
2/5
03:49 pm
cor
Cencora (COR) Stock Trades Up, Here Is Why [Yahoo! Finance]
Low
Report
Cencora (COR) Stock Trades Up, Here Is Why [Yahoo! Finance]
2/5
09:41 am
cor
Cencora (NYSE:COR) had its price target lowered by analysts at Evercore ISI from $440.00 to $420.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora (NYSE:COR) had its price target lowered by analysts at Evercore ISI from $440.00 to $420.00. They now have an "outperform" rating on the stock.
2/5
01:26 am
cor
Cencora Q1 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Cencora Q1 Earnings Call Highlights [Yahoo! Finance]
2/4
10:12 am
cor
Cencora (COR) Q1 2026 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Cencora (COR) Q1 2026 Earnings Call Transcript [Yahoo! Finance]
2/4
08:40 am
cor
Cencora beats quarterly profit estimates on strong demand for specialty medicines [Yahoo! Finance]
Medium
Report
Cencora beats quarterly profit estimates on strong demand for specialty medicines [Yahoo! Finance]
2/4
08:11 am
cor
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates [Yahoo! Finance]
Medium
Report
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates [Yahoo! Finance]
2/4
07:26 am
cor
Cencora Reports Fiscal 2026 First Quarter Results [Yahoo! Finance]
Medium
Report
Cencora Reports Fiscal 2026 First Quarter Results [Yahoo! Finance]
2/4
06:30 am
cor
Cencora Reports Fiscal 2026 First Quarter Results
Medium
Report
Cencora Reports Fiscal 2026 First Quarter Results
2/2
10:11 pm
cor
Cencora (COR) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Low
Report
Cencora (COR) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
1/31
07:03 pm
cor
How Investors May Respond To Cencora (COR) Deepening Its Rare Disease Services Through Curant Collaboration [Yahoo! Finance]
Low
Report
How Investors May Respond To Cencora (COR) Deepening Its Rare Disease Services Through Curant Collaboration [Yahoo! Finance]
1/31
09:57 am
cor
Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)'s Growth Story Gains Momentum [Yahoo! Finance]
Low
Report
Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)'s Growth Story Gains Momentum [Yahoo! Finance]
1/29
12:32 pm
cor
Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors [Seeking Alpha]
Low
Report
Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors [Seeking Alpha]